Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash Flows from Operating Activities:
Net income	$ 2,123,000,000	$ 1,115,000,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	844,000,000	842,000,000
Amortization of purchased intangibles	46,000,000	40,000,000
Restructuring, impairment and other charges	78,000,000	0
Stock compensation charges	33,000,000	36,000,000
Equity in earnings of affiliated companies	(119,000,000)	(195,000,000)
Dividends received from affiliated companies	20,000,000	143,000,000
Deferred tax (benefit) provision	(1,047,000,000)	187,000,000
Restructuring payments	(10,000,000)	(38,000,000)
Employee benefit payments less than expense	0	5,000,000
Losses (gains) on foreign currency hedges related to translated earnings	2,295,000,000	(42,000,000)
Unrealized translation (gains) losses on transactions	(177,000,000)	303,000,000
Contingent consideration fair value adjustment	(40,000,000)
Gain on realignment of equity investment	(2,676,000,000)	0
Changes in certain working capital items:
Trade accounts receivable	(184,000,000)	52,000,000
Inventories	(69,000,000)	(60,000,000)
Other current assets	(42,000,000)	(204,000,000)
Accounts payable and other current liabilities	14,000,000	(294,000,000)
Other, net	6,000,000	(45,000,000)
Net cash provided by operating activities	1,095,000,000	1,845,000,000
Cash Flows from Investing Activities:
Capital expenditures	(815,000,000)	(939,000,000)
Acquisitions of business, net of cash acquired	(279,000,000)	(531,000,000)
Investment in unconsolidated entities	(14,000,000)	(33,000,000)
Cash	4,818,000,000	0
(Payments) proceeds from loan repayments from unconsolidated entities	(10,000,000)	6,000,000
Short-term investments – acquisitions	(20,000,000)	(859,000,000)
Short-term investments – liquidations	121,000,000	1,046,000,000
Realized gains on foreign currency hedges related to translated earnings	146,000,000	489,000,000
Other, net	9,000,000	(1,000,000)
Net cash provided by (used in) investing activities	3,956,000,000	(822,000,000)
Cash Flows from Financing Activities:
Net repayments of short-term borrowings and current portion of long-term debt	(85,000,000)	0
Principal payments under capital lease obligations	(1,000,000)	(1,000,000)
Proceeds from issuance of short-term debt	0	2,000,000
Proceeds from issuance of long-term debt	0	745,000,000
Payments from issuance of commercial paper	(481,000,000)	0
Payments from settlement of interest rate swap arrangements	0	(10,000,000)
Proceeds from the exercise of stock options	(86,000,000)	(99,000,000)
Repurchases of common stock for treasury	(3,884,000,000)	(1,905,000,000)
Dividends paid	(493,000,000)	(519,000,000)
Net cash used in financing activities	(4,858,000,000)	(1,589,000,000)
Effect of exchange rates on cash	128,000,000	(303,000,000)
Net increase (decrease) in cash and cash equivalents	321,000,000	(869,000,000)
Cash and cash equivalents at beginning of period	4,500,000,000	5,309,000,000
Cash and cash equivalents at end of period	$ 4,821,000,000	$ 4,440,000,000